Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities:
Net income	$ 71,114	$ 304,245
Loss (income) from discontinued operations	7,088	(341,337)
Income (loss) from continuing operations	78,202	(37,092)
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	10,908	18,604
Amortization and impairments to operating lease assets	37,928	35,251
Depreciation	31,618	33,471
Amortization of intangible assets	48,936	73,967
Amortization and write-off of debt discount and issuance costs	7,974	34,481
Provision for bad debts	23,391	19,552
Deferred income taxes	(1,718)	3,425
Loss on disposals, accelerated depreciation, and impairments to property and equipment	3,999	2,274
Gain on extinguishment of debt	(71)	0
Loss on investments	4,122	807
Gain on sale of assets	(13,317)	0
Changes in assets and liabilities:
Accounts receivable	(43,345)	(40,520)
Prepaid expenses and other current assets	7,034	2,398
Accounts payable	12,286	(5,737)
Accrued payroll and benefits	(11,719)	(22,416)
Accrued liabilities	(20,275)	(92,528)
Deferred revenue	26,038	92,507
Operating lease liabilities	(37,758)	(36,159)
Other assets and liabilities	(14,412)	(23,514)
Net cash provided by operating activities-continuing operations	149,821	58,771
Net cash used in operating activities-discontinued operations	(404)	(6,915)
Net cash provided by operating activities	149,417	51,856
Investing activities:
Capital expenditures	(19,056)	(22,249)
Proceeds from sale of marketable securities	7,635	941
Purchases of marketable securities	(1,508)	(1,315)
Payment for purchase of business, net of cash and restricted cash acquired	0	(1,488,054)
Net cash provided by (used in) investing activities-continuing operations	33,871	(1,500,677)
Net cash used in investing activities-discontinued operations	0	(3,287)
Proceeds from sale of business, net of cash transferred	0	962,652
Payment for working capital adjustment for sale of business	(3,174)	0
Net cash provided by (used in) investing activities	30,697	(541,312)
Financing activities:
Proceeds from exercise of stock options	1,622	8,433
Employee taxes paid on withholding shares	(4,214)	(2,727)
Proceeds from stock issued under Colleague Stock Purchase Plan	451	400
Repurchases of common stock for treasury	(44,710)	(120,000)
Payment on equity forward contract	(13,162)	(30,000)
Proceeds from long-term debt	0	850,000
Repayments of long-term debt	(150,861)	(687,667)
Payment of debt discount and issuance costs	0	(49,553)
Payment for purchase of redeemable noncontrolling interest of subsidiary	0	(1,790)
Net cash used in financing activities	(210,874)	(32,904)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	12
Net decrease in cash, cash equivalents and restricted cash	(30,760)	(522,348)
Cash, cash equivalents and restricted cash at beginning of period	347,937	1,313,616
Cash, cash equivalents and restricted cash at end of period	317,177	791,268
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period	0	1,273
Cash, cash equivalents and restricted cash of continuing operations at end of period	317,177	789,995
Non-cash investing and financing activities:
Accrued capital expenditures	10,474	5,408
Accrued liability for repurchases of common stock	2,699	0
Accrued excise tax on share repurchases	361	0
Settlement of financing liability with assets	38,606	0
DePaul College Prep
Investing activities:
Proceeds from note receivable related to property sold	46,800	0
DeVry University
Investing activities:
Proceeds from note receivable related to property sold	$ 0	$ 10,000